SpecGx, a subsidiary of Mallinckrodt Pharmaceuticals, was the top opioid manufacturer between 2006 and 2012, accounting for 37.7 percent of the pills on the U.S. market, according to Drug Enforcement Administration data published by The Washington Post.
The DEA's prescription opioid database contains manufacturing and distribution information for every pain pill sold in the U.S. The Post gained access to the database after a yearlong legal battle.
The publication reviewed nearly 380 million transactions involving oxycodone and hydrocodone from 2006-12 and found more than 76 billion pills were distributed in the U.S over that time period.
Here are the five largest manufacturers of these pills, ranked by market share:
- SpecGx — 37.7 percent
- Actavis Pharma — 34.5 percent
- Par Pharmaceutical — 15.7 percent
- Purdue Pharma — 3.3 percent
- Amneal Pharmaceuticals — 2.9 percent
To access more data from The Washington Post, click here.
More articles on opioids:
McKinsey under fire for consulting on opioid sales
Utah university receives $175K for opioid prevention, telemedicine program
2% of US women continue using opioids after childbirth, study finds